Literature DB >> 2606818

The susceptibility to amoxycillin/clavulanate of Enterobacteriaceae with plasmid-mediated ampicillin resistance: a twelve-year study of strains in one Spanish hospital.

M C Rubio1, J Gil, J Castillo, I Otal, M L Gómez-Lus, E Rubio, C Sarraseca, A Torrellas, R Gómez-Lus.   

Abstract

We studied the antibacterial activity of amoxycillin, clavulanic acid and the combination, against 1210 clinical isolates with plasmid-mediated ampicillin resistance, isolated at the Zaragoza Clinical University Hospital during 12 years. MICs were determined by an agar dilution technique with an inoculum of 10(4) cfu per spot. MIC50 values of amoxycillin/clavulanate ranged from 8 to 16 mg/l. The antibacterial activity of amoxycillin/clavulanate did not show any statistically significant variation during the 12-year period.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2606818     DOI: 10.1093/jac/24.suppl_b.35

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  4 in total

Review 1.  Enterobacter spp.: pathogens poised to flourish at the turn of the century.

Authors:  W E Sanders; C C Sanders
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

2.  TEM-80, a novel inhibitor-resistant beta-lactamase in a clinical isolate of Enterobacter cloacae.

Authors:  Corinne Arpin; Roger Labia; Véronique Dubois; Patrick Noury; Muriel Souquet; Claudine Quentin
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

Review 3.  beta-Lactamases in laboratory and clinical resistance.

Authors:  D M Livermore
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

4.  Molecular epidemiology of the plasmid-encoded TEM-1 beta-lactamase in Scotland.

Authors:  C J Thomson; S G Amyes
Journal:  Epidemiol Infect       Date:  1993-02       Impact factor: 2.451

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.